Vera Therapeutics stock rose on FDA acceptance of atacicept BLA for priority review in IgAN, a potential multi-billion dollar ...
Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).
Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback